Bone marrow as a cell source for tissue engineering heart valves

Tjörvi E. Perry, Sunjay Kaushal, Fraser W.H. Sutherland, Kristine J. Guleserian, Joyce Bischoff, Michael Sacks, John E. Mayer, Alexander Kadner, Paul Kurlansky, Charles B. Huddleston

Research output: Contribution to journalArticlepeer-review

116 Scopus citations


Background. This study was designed to assess the feasibility of using ovine bone marrow-derived mesenchymal stem cells to develop a trileaflet heart valve using a tissue engineering approach. Methods. Bone marrow was aspirated from the sternum of adult sheep. Cells were isolated using a Ficoll gradient, cultured, and characterized based on immunofluorescent staining and the ability to differentiate down a specific cell lineage. Two million cells per centimeter squared were delivered onto a polyglycolic acid (PGA), poly-4-hydroxybutyrate (P4HB) composite scaffold and cultured for 1 week before being transferred to a pulse duplicator for an additional 2 weeks. The tissue-engineered valves were assessed by histology, scanning electron microscopy, and biomechanical flexure testing. Results. Cells expressed SH2, a marker for mesenchymal stem cells, as well as specific markers of smooth muscle cell lineage including α-smooth muscle actin, desmin, and calponin. These cells could be induced to differentiate down an adipocyte lineage confirming they had not fully committed to a specific cell lineage. Preliminary histologic examination showed patchy surface confluency confirmed by scanning electron microscopy, and deep cellular material. Biomechanical flexure testing of the leaflets showed an effective stiffness comparable to normal valve leaflets. Conclusions. Mesenchymal stem cells can be isolated noninvasively from the sternum of sheep and can adhere to and populate a PGA/P4HB composite scaffold to form "tissue" that has biomechanical properties similar to native heart valve leaflets. Thus, bone marrow may be a potential source of cells for tissue engineering trileaflet heart valves, particularly in children with congenital heart disease.

Original languageEnglish (US)
Pages (from-to)761-767
Number of pages7
JournalAnnals of Thoracic Surgery
Issue number3
StatePublished - Mar 1 2003

Bibliographical note

Funding Information:
The Thoracic Surgery Directors Association (TSDA) Resident Research Award, sponsored by Medtronic, Inc, was established in 1990 to encourage resident research in cardiothoracic surgery. Abstracts submitted to The Society of Thoracic Surgeons (STS) Program Committee representing research performed by residents were forwarded to the TSDA to be considered for this award. The abstracts were selected by the TSDA Executive Committee consisting of Edward D. Verrier, President, Douglas J. Mathisen, President-Elect, Jeffrey P. Gold, Secretary/Treasurer, Gordon N. Olinger, MD, Immediate Past President, John H. Calhoon, Councillor-at-Large, and Richard J. Shemin, Councillor-At-Large.

Funding Information:
This work was supported by a National Institutes of Health grant 1 RO1 HL60463-02. We thank Drs Frederick Schoen and Elena Rabkin for the preparation and interpretation of the histology. We acknowledge Karen Hodgins for preparation of the scanning electron microscopy photographs and Kristine Gullage for the preparation of the illustrations.


Dive into the research topics of 'Bone marrow as a cell source for tissue engineering heart valves'. Together they form a unique fingerprint.

Cite this